Author

Albert Xu

Sanofi (United States)Primary ORCID profile (0000-0001-5938-561X · 9 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Albert XuiD9 papers · University of California, San Francisco

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:protein structure· 1 Research Focus:protein structure prediction· 1 Approach:simulation· 1 Approach:statistical model· 1

Frequent Co-Authors

Anna ParkiD· 1 shared Egor SvidritskiyiD· 1 shared Maria WendtiD· 1 shared Yanfeng ZhouiD· 1 shared Yu QiuiD· 1 shared Yuri Iozzo· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Anna ParkORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Development of an integrated structural biology platform specialized for sub-100 kDa protein complexes to support biologics discovery and rational engineering

Yuri Iozzo, Egor Svidritskiy, Yu Qiu, Albert Xu, Anna Park, Maria Wendt, Yanfeng Zhou

The paper describes a platform integrating structural biology tools to rapidly determine structures of sub-100 kDa protein complexes, enabling efficient biologics discovery and engineering.

Antibody Therapeutics · Oct 30, 2021Peer-reviewedMolecular Biology